Announcement of scheduled reappointment of all six directors as of April 1, 2026, and at the shareholders meeting planned for June 2026, along with changes in executive officers.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4528","jir_company_name":"Ono Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-03-02","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/03\/4528-20260302-01.pdf","jir_short_summary":"Announcement of scheduled reappointment of all six directors as of April 1, 2026, and at the shareholders meeting planned for June 2026, along with changes in executive officers.","jir_summary":"### Overview of Director Personnel Changes\nOno Pharmaceutical Co., Ltd. announced that all six current directors are scheduled for reappointment at the 78th Annual General Shareholders Meeting to be held in June 2026. This includes President and Representative Director Juichi Takino and three outside directors who will continue to serve as directors. This is expected to maintain management stability.\n\n### Overview and Impact of Executive Officer Personnel Changes\nExecutive officer changes will take effect on April 1, 2026. Satoshi Tsujinaka will be appointed as Representative Director and Executive Vice President, concurrently overseeing multiple headquarters and divisions. Additionally, some positions of Managing Executive Officers and Executive Officers will be revised, clarifying roles such as Head of Sustainability Promotion and Head of EHS Promotion. These personnel changes aim to promote management strategies and strengthen the organization, contributing to the company\u2019s sustainable growth.","jir_financial_highlights":"Number of Directors Scheduled for Reappointment: 6 (Unknown)\nEffective Date of Executive Officer Changes: 2026-04-01 (Unknown)\nScheduled Shareholders Meeting Date: June 2026 (Unknown)","jir_category":"","jir_hashtags":"#OnoPharmaceutical, #ExecutivePersonnelChanges, #JapaneseStocks","jir_key_figures":"Number of Directors Scheduled for Reappointment: 6 (scheduled for June 2026)\nEffective Date of Executive Officer Changes: 2026-04-01\nNumber of Outside Directors Scheduled for Reappointment: 3","jir_meta_title":"Ono Pharmaceutical Announces 2026 Directors and Executive Officer Personnel Changes \u2013 All Six Directors Scheduled for Reappointment","jir_meta_description":"Ono Pharmaceutical plans to reappoint all six directors at the June 2026 shareholders meeting and will implement executive officer changes effective April 1, 2026, announcing personnel measures to stabilize management and strengthen the organization.","jir_og_title":"Ono Pharmaceutical Announces 2026 Directors and Executive Officer Personnel Changes","jir_og_description":"Ono Pharmaceutical announces the scheduled reappointment of six directors and changes in executive officers to strengthen its management framework.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7530,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"executive_change","footnotes":""},"sector":[],"importance":[],"class_list":["post-32287","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n